by clearskymd | Mar 24, 2022 | Company News
ClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia. It is estimated that between five and 20 per cent of people aged over 65...
by clearskymd | Jan 11, 2022 | Company News
ClearSky Medical Diagnostics is supporting a new initiative to better understand the development of children’s brains during their early stages of life. The Wellcome Leap Program’s The First 1000 Days – Promoting Healthy Brain Networks project focuses on the...
by clearskymd | Dec 8, 2021 | Company News
ClearSky Medical Diagnostics and Shanghai Accurature Diagnostics Co Ltd have entered into a strategic cooperation agreement related to PD-Monitor. PD-Monitor is a medical device using ClearSky’s proprietary AI technology to assist the diagnosis and measurements of...
by clearskymd | Dec 14, 2020 | Company News
Professor Stephen Smith highlighted the work of ClearSky Medical Diagnostics in diagnosing and monitoring Parkinson’s at a UK–China university consortium in November. The UK-Jiangsu World-Class University Consortium is a group of more than 30 leading...
by clearskymd | Nov 16, 2020 | Company News
ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s. Statins, such as Simvastatin, are a group of medicines that are currently prescribed to lower cholesterol in the blood....
by clearskymd | Sep 24, 2020 | Company News
ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology. Data science company StartUs Insights, which identifies startups, disruptive technologies and new business models early-on, selected...
Recent Comments